Table 2.
Univariate and multivariate analysis of clinicopathologic factors associated with DFS in PTC cases.
| Patient characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| P value | HR | 95% CI | P value | |
| Age | ||||
| <55 vs | ||||
| ≥55 | 0.736 | 1.986 | 0.546–7.226 | 0.298 |
| Sex | ||||
| Male vs | ||||
| Female | 0.362 | 1.258 | 0.281–5.643 | 0.764 |
| TNM stage | ||||
| I vs II vs | ||||
| III vs IV | 0.061 | 1.043 | 0.488–2.231 | 0.913 |
| Tumour size | ||||
| <2 cm vs | ||||
| ≥2 cm | 0.327 | 0.956 | 0.253–3.608 | 0.947 |
| Multifocality | ||||
| Present vs | ||||
| Absent | 0.128 | 2.340 | 0.604–9.063 | 0.219 |
| Extrathyroidal extension | ||||
| Present vs | ||||
| Absent | 0.154 | 1.050 | 0.260–4.241 | 0.945 |
| Lymphovascular invasion | ||||
| Present vs | ||||
| Absent | 0.004* | 2.826 | 0.416–19.188 | 0.288 |
| Lymph node metastases | ||||
| Present vs | ||||
| Absent | 0.006* | 1.819 | 0.441–7.515 | 0.408 |
| Concurrent Hashimoto’s thyroiditis | ||||
| Present vs | ||||
| Absent | 0.424 | 0.900 | 0.242–3.346 | 0.875 |
| PD-L1 | ||||
| Negative vs | ||||
| Positive | 0.048* | 3.053 | 0.599–15.552 | 0.179 |
| CD8 | ||||
| Negative vs | ||||
| Positive | 0.028* | 0.536 | 0.135–2.130 | 0.376 |
| EMT status | ||||
| E-cadneg/Vimneg vs | ||||
| E-cadneg/Vimpos vs | ||||
| E-cadpos/Vimneg vs | ||||
| E-cadpos/Vimpos | 0.026* | 3.132 | 1.102–8.897 | 0.032* |
This work is licensed under a